State boards of pharmacy have issued cease-and-desist letters, license suspensions, and disciplinary actions against pharmacies that: Compounded semaglutide salt forms
Grip strength and rotarod assessed motor function at baseline, three months, and six months
The IRS treats prescribed drugs for a diagnosed disease as qualified medical expenses under Section 213(d), so GLP-1s can be eligible on paper but employer-funded HRAs, and to a lesser extent FSAs and HSAs, are governed by plan documents that can be narrower than IRS rules
Miao Cai, Ph.D., from the VA Saint Louis Health Care System, and colleagues examined whether initiation of GLP-1 receptor agonists is associated with a reduced risk for incident SUDs in people with no history of SUD (protocol 1) or with a reduced risk for SUD-related adverse clinical outcomes among people with a preexisting SUD (protocol 2)
[DOI] [PMC free article] [PubMed] [Google Scholar] 88.Urscher M, More SS, Alisch R, Vince R, Deponte M
In short, GLP-1 drugs represent both a challenge and an opportunity in the food and beverage industry
